Anthony Napolitano
Square Vape Labs Inc.
779 Hempstead Turnpike
Franklin Square , NY 11010
United States
admin@squarevapelabs.comIssued Feb 26, 2021Center for Tobacco Products
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.
Violations1
Issue DateFeb 26, 2021
Product TypeTobacco
StatusClosed
Closeout LetterJul 21, 2021
Letter Details
Firm
Square Vape Labs Inc.
Location
Anthony Napolitano
Square Vape Labs Inc.
779 Hempstead Turnpike
Franklin Square , NY 11010
United States
admin@squarevapelabs.com
FEI Number
N/A
Country
United States
Issue Date
February 26, 2021
Issuing Office
Center for Tobacco Products
Product Type
Tobacco
Status
Closed
Closeout Letter
July 21, 2021
Summary
Square Vape Labs Inc. was cited for manufacturing and distributing e-liquid tobacco products without required premarket authorization orders, in violation of the Family Smoking Prevention and Tobacco Control Act. The FDA determined that e-liquids sold through the company's website were "new tobacco products" subject to FDA jurisdiction under section 910 of the Federal Food, Drug, and Cosmetic Act, requiring marketing authorization before legal sale in the United States. The company failed to obtain the necessary premarket authorization orders for these products before offering them for sale or distribution.
Square Vape Labs Inc. FDA Warning Letter, February 26, 2021